Myofibroblast transdifferentiation is associated with changes in cellular and extracellular vesicle miRNA abundance.
Ontology highlight
ABSTRACT: Transforming growth factor-beta 1 (TGF-β1), a pro-fibrotic tumour-derived factor promotes fibroblast differentiation in the tumour microenvironment and is thought to contribute to the development of pro-tumourigenic cancer-associated fibroblasts (CAFs) by promoting myofibroblast differentiation. miRNA dysregulation has been demonstrated in myofibroblast transdifferentiation and CAF activation, however, their expression varies among cell types and with the method of fibroblast induction. Here, the expression profile of miRNA in human primary oral fibroblasts treated with TGF-β1, to derive a myofibroblastic, CAF-like phenotype, was determined compared to untreated fibroblasts. Myofibroblast transdifferentiation was determined by the expression of alpha-smooth muscle actin (α-SMA) and fibrone
SUBMITTER: Zainal Abidin SAI
PROVIDER: S-EPMC8584782 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA